The WHO Global Benchmarking Tool
A game changer for strengthening national regulatory capacity
Bibliographic Data
| ID | 21879783 |
|---|---|
| Authors | JAVIER GUZMÁN (0000-0002-8194-039X, Management Sciences for Health, corresponding author), Erin O’Connell (0000-0002-2850-3465, Management Sciences for Health), Kate Kikule (Management Sciences for Health), Tamara Hafner (0000-0002-4710-0979, Management Sciences for Health) |
| Year | 2020 |
| Volume | 5 |
| Issue | 8 |
| Pages | e003181 |
| Publication date | 2020-08-01 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | BMJ Global Health (JOURNAL) |
| Journal identifiers | ISSN: 2059-7908 • E-ISSN: 2059-7908 |
| Publisher | BMJ (PUBLISHER • GB) |
| DOI | 10.1136/bmjgh-2020-003181 |
| PMID | 32784212 |
| OpenAlex | W3048872753 |
| Language | EN |
| Citations received | 5 |
| References cited | 6 |
Many low-income and middle-income countries lack the capacity to effectively and efficiently regulate medical products in their countries. To support countries in strengthening their capacity, WHO has developed the Global Benchmarking Tool (GBT) as the global standard for objectively assessing regulatory capacity for medicines and vaccines. The GBT is a game changer because it is the first globally accepted tool for assessing and strengthening national regulatory authorities. The inclusion of an institutional development plan in the GBT methodology provides context-specific actionable steps countries can take to advance their system’s functionality and maturity. The GBT facilitates coordination and improves the effectiveness of regulatory strengthening efforts. The tool also facilitates regulatory reliance and harmonisation, which helps to improve timely access to quality-assured medicines, and creates incentives for trade, particularly in countries and regions with a strong pharmaceutical manufacturing base. The GBT is a necessary tool for creating strong and effective regulatory systems, which are critical for ensuring the efficacy, safety and quality assurance of medicines and populations’ timely access to these medicines. In outlining the benefits of the GBT, this paper also offers some specific ideas for strengthening the GBT framework and process
Benchmarking · Business · Capacity building · Economic growth · Economics · Incentive · Political science · Process management · Public economics · Biotechnology and Related Fields · Computer Science · Pharmaceutical Economics and Policy · Pharmaceutical Quality and Counterfeiting · Marketing
Nearly one in five essential medicines fail quality standards in Africa
Uncertainties about the quality of medical products globally
Strengthening regulatory systems for medicines in a changed world
How the concept of WHO-listed authorities will change international procurement policies for medicines
Best practices in the African Medicines Regulatory Harmonization initiative
| Citations per year | 1 |
|---|---|
| Citation span | 2021 - 2026 (6) |
| Highly cited | No |